BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laes JF, Sauvage S, Ghitti G. Tumor-biopsy stratification based on mTOR-pathway activity and functional mutations in the upstream genes PIK3CA and PTEN. Oncotarget 2017;8:84426-33. [PMID: 29137436 DOI: 10.18632/oncotarget.21348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Kundishora AJ, Singh AK, Allington G, Duy PQ, Ryou J, Alper SL, Jin SC, Kahle KT. Genomics of human congenital hydrocephalus. Childs Nerv Syst 2021. [PMID: 34232380 DOI: 10.1007/s00381-021-05230-8] [Reference Citation Analysis]
2 Chan TG, O'Neill E, Habjan C, Cornelissen B. Combination Strategies to Improve Targeted Radionuclide Therapy. J Nucl Med 2020;61:1544-52. [PMID: 33037092 DOI: 10.2967/jnumed.120.248062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Gong J, Pan K, Fakih M, Pal S, Salgia R. Value-based genomics. Oncotarget 2018;9:15792-815. [PMID: 29644010 DOI: 10.18632/oncotarget.24353] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
4 Wichmann CW, Goh YW, Parslow AC, Rigopoulos A, Guo N, Scott AM, Ackermann U, White JM. Synthesis and validation of [18F]mBPET-1, a fluorine-18 labelled mTOR inhibitor derivative based on a benzofuran backbone. EJNMMI Radiopharm Chem 2020;5:3. [PMID: 31974638 DOI: 10.1186/s41181-020-0089-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]